glp-1 heart rate increase The autonomic nervous system and cardiac receptors control in mice Cardiovascular Effects of Glucagon-Like Peptide-1

Structure of the human glucagon class B G-protein-coupled receptor

[11] [12] Currently available GLP-1 receptor agonists in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist

They address common concerns such as constipation/diarrhea, nausea, bone and muscle loss with weight loss, gallbladder disease vs pancreatitis risk, Ozempic face, thyroid cancer fears, and cautions about compounded GLP1s, emphasizing seeing an obesity medicine specialist and registered dietitian.

Semaglutide has become a popular option for weight loss, including for those dealing with menopause-related weight gain

Its possible

It is also important to recognize that adherence is not fixed